Page last updated: 2024-08-23

razoxane and Hemangiosarcoma

razoxane has been researched along with Hemangiosarcoma in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eiter, H; Ginestet, A; Hackl, A; Lukas, P; Pakisch, B; Pokrajac, B; Pötter, R; Rhomberg, W; Wink, A1
Breitfellner, G; Eiter, H; Fritzsche, H; Gruber-Mösenbacher, U; Rhomberg, W1
Grass, M; Rhomberg, W1

Reviews

1 review(s) available for razoxane and Hemangiosarcoma

ArticleYear
[Angiosarcoma of the right atrium: local control via low radiation doses and razoxane. A case report].
    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 1999, Volume: 175, Issue:3

    Topics: Aged; Antineoplastic Agents; Chemotherapy, Adjuvant; Fatal Outcome; Heart Atria; Heart Neoplasms; Hemangiosarcoma; Humans; Liver Neoplasms; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Radiotherapy Dosage; Radiotherapy, Adjuvant; Razoxane

1999

Trials

1 trial(s) available for razoxane and Hemangiosarcoma

ArticleYear
Treatment of vascular soft tissue sarcomas with razoxane, vindesine, and radiation.
    International journal of radiation oncology, biology, physics, 2009, May-01, Volume: 74, Issue:1

    Topics: Aged; Drug Administration Schedule; Female; Hemangiopericytoma; Hemangiosarcoma; Humans; Male; Middle Aged; Radiation-Sensitizing Agents; Radiotherapy Dosage; Razoxane; Vindesine

2009

Other Studies

1 other study(ies) available for razoxane and Hemangiosarcoma

ArticleYear
[Prognosis and epidemiology of malignant hemangioendotheliomas of the thyroid gland].
    Schweizerische medizinische Wochenschrift, 1993, Sep-04, Volume: 123, Issue:35

    Topics: Aged; Austria; Combined Modality Therapy; Female; Hemangiosarcoma; Humans; Incidence; Male; Middle Aged; Prognosis; Radiotherapy Dosage; Razoxane; Thyroid Neoplasms

1993